Back to dashboard
All PlansAdministrativeMedium impact

MA08.065l, Octreotide Acetate (Sandostatin® LAR Depot)

Independence Blue Cross·Pharmacy
Effective date
Not stated
We identified it
Jun 30, 2026
Days to comply

Summary

Failed to analyze policy change

Action Required

Action needed
Manual review required